Conditions & Recovery · Immunotherapy Updates · August 7, 2026

First patient dosed with DISP-10 in Dispatch Bio’s cancer trial - Yahoo

Explore the original story for the publisher’s full reporting.

Originally published by Immunotherapy Updates. We curate and add context; they did the reporting.

Related learning